November 16, 2021 Comments Off on New patent for NOVO drug RYBELSUS Posted in: Patent Added Annual Drug Patent Expirations for RYBELSUS Rybelsus is a drug marketed by Novo and is included in one NDA. It is available from one supplier. There are seven patents protecting…
The post New patent for NOVO drug RYBELSUS appeared first on DrugPatentWa…
November 16, 2021 Comments Off on New patent for Beigene drug BRUKINSA Posted in: Patent Added Annual Drug Patent Expirations for BRUKINSA Brukinsa is a drug marketed by Beigene and is included in one NDA. There are three patents protecting this drug. This drug has thirty-six…
The post New patent for Beigene drug BRUKINSA appeared first on DrugP…
